+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Caprion Biosciences - logo

Caprion Pharmaceuticals is a drug discovery and development company engaged in the discovery and development of proteomics pharmaceutical products in oncology and infectious disease. The company's clinical-stage programs include Shigamabs, a product for the treatment of shigatoxin-producing bacterial infections, and CAP-232, a therapy with potential efficacy in multiple oncology indications. Caprion Pharmaceuticals, Inc. was founded in 1998 and is based in Montreal, Canada.

From
From
From
From
From
Proteomics Global Market - Forecast to 2026 - Product Thumbnail Image

Proteomics Global Market - Forecast to 2026

  • Report
  • March 2020
  • 471 Pages
From
From
Proteomics - Global Market Trajectory & Analytics - Product Thumbnail Image

Proteomics - Global Market Trajectory & Analytics

  • Report
  • July 2020
  • 312 Pages
From
Proteomics: Technologies and Global Markets - Product Thumbnail Image

Proteomics: Technologies and Global Markets

  • Report
  • September 2018
  • 235 Pages
From
Protein Analysis: Subfocus on Oncoproteomics - Product Thumbnail Image

Protein Analysis: Subfocus on Oncoproteomics

  • Report
  • September 2018
  • 231 Pages
From
From
From
Biomarkers: Technologies and Global Markets - Product Thumbnail Image

Biomarkers: Technologies and Global Markets

  • Report
  • August 2018
  • 171 Pages
From
From
From
Loading Indicator
adroll